Keywords: Liver, Quantitative Imaging
Motivation: Patients with MASH have increased inflammation and insulin resistance, however whether this translates to dampened liver fat reduction after weight loss is not known.
Goal(s): Our goal was to assess if patients with MASH have altered liver fat reduction after weight loss.
Approach: Baseline MASH status was determined in participants with obesity via biopsy during metabolic bariatric surgery. Liver PDFF was assessed by MRI pre-op and 12 months post-op and the changes were compared between groups.
Results: Participants with MASH had dampened reduction of liver PDFF after metabolic bariatric surgery when controlling for baseline PDFF.
Impact: For patients with obesity and MASH, adjuvant treatment may be needed to achieve the same total goal reduction in liver fat as patients without MASH.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords